Double-digit growth: FIGS (NYSE: FIGS) posts strong 2025 results and upbeat 2026 outlook
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
FIGS, Inc. reported strong fourth quarter and full year 2025 results, with clear acceleration exiting the year and a bullish 2026 outlook. Q4 2025 net revenues rose 33.0% to $201.9 million, driven by more orders from new and existing customers and higher average order value. Net income jumped to $18.5 million (diluted EPS $0.10) and net income margin expanded to 9.2%, despite a 440-basis-point gross margin decline to 62.9% from higher tariffs and a $5.6 million inventory write-off.
For full year 2025, net revenues grew 13.6% to $631.1 million, with scrubwear up 14.3% and international revenue up 27.5%. Net income increased to $34.3 million (diluted EPS $0.19), and net income margin improved to 5.4%. Adjusted EBITDA was $74.5 million with an 11.8% margin, and free cash flow was $53.0 million. Active customers reached 2.9 million, net revenues per active customer were $216, and average order value was $120, all up year over year.
FIGS guides 2026 net revenues growth of 10–12% and an adjusted EBITDA margin of 12.7–12.9%, targeting low‑20% revenue growth in Q1 2026 while expecting further profitability gains even with new 15% global tariffs.
Positive
- None.
Negative
- None.
Insights
FIGS posts sharp profit rebound, strong Q4 acceleration and guides double‑digit 2026 growth.
FIGS delivered a powerful turnaround in 2025. Q4 net revenues grew
Profitability improved meaningfully despite headwinds. Q4 gross margin declined to
Customer metrics show healthy engagement: active customers reached 2.9 million, net revenues per active customer were
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): | ||
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||||||||
Registrant’s Telephone Number, Including Area Code: | ||
| Not Applicable | ||
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 2.02 Results of Operations and Financial Condition.
On February 26, 2026, FIGS, Inc. (the “Company”) announced its financial results for the three months and fiscal year ended December 31, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this “Report”).
Item 7.01 Regulation FD Disclosure.
On February 26, 2026, the Company posted a financial highlights presentation to the “Investor Relations” portion of its website at ir.wearfigs.com/financials/quarterly-results.
The information in Items 2.02 and 7.01 of this Report (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | ||||
| 99.1* | Press Release of the Company, dated February 26, 2026 | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
| * | This exhibit related to Item 2.02 shall be deemed to be furnished, and not filed. | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| FIGS, INC. | |||||||||||
| Date: | February 26, 2026 | By: | /s/ Sarah Oughtred | ||||||||
| Name: | Sarah Oughtred | ||||||||||
| Title: | Chief Financial Officer | ||||||||||
FIGS Releases Fourth Quarter and Full Year 2025 Financial Results
Exceeded Top and Bottom Line Expectations
Grew Q4 2025 Net Revenues 33.0% to a Record $201.9 Million
Achieved Q4 2025 Net Income Margin of 9.2% and Adjusted EBITDA Margin of 13.2%
Plans Low Double-Digit Net Revenues Growth and Margin Expansion in FY 2026
SANTA MONICA, Calif., February 26, 2026 — FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.
Fourth Quarter 2025 Financial Highlights
•Net revenues were $201.9 million, an increase of 33.0% year over year, primarily due to an increase in orders from new and existing customers and higher average order value (“AOV”).(1)
•Scrubwear net revenues were $154.9 million, an increase of 35.1% year over year.
•Non-scrubwear net revenues were $47.0 million, an increase of 26.4% year over year.
•U.S. net revenues were $164.2 million, an increase of 28.7% year over year.
•International net revenues were $37.7 million, an increase of 55.1% year over year.
•Gross margin was 62.9%, a decrease of 440 basis points year over year, reflecting higher tariffs and lapping the benefit from duty drawback claims in the same period last year. Additionally, results reflect a $5.6 million inventory write-off recorded during the period. These headwinds were partially offset by a lower discount rate in the period, as well as favorable freight rates.
•Operating expenses were $108.3 million, an increase of 16.0% year over year. As a percentage of net revenues, operating expenses decreased to 53.6% from 61.4% in the same period last year, primarily due to lower stock-based compensation expense, lower fulfillment and shipping expenses, and fixed cost leverage.
•Net income was $18.5 million, or $0.10 in diluted earnings per share, compared to net income of $1.9 million, or $0.01 in diluted earnings per share, in the same period last year.
•Net income margin(2) was 9.2%, as compared to 1.2% in the same period last year.
•Adjusted EBITDA(3) was $26.7 million, an increase of $5.7 million year over year.
•Adjusted EBITDA margin(2)(3) was 13.2%, as compared to 13.9% in the same period last year.
“FIGS’ fourth quarter performance capped off a remarkable 2025, driven by execution that gained steady momentum throughout the year,” said Trina Spear, Chief Executive Officer and Co-Founder. “Our 33% surge in Q4 net revenues was driven by successes across virtually every part of the business, while also lowering our discount rate for the period. With the COVID overhang past us and the structural advantages of this industry as tailwinds, we’re excited to see our sustained success over the past few quarters continue into 2026. The opportunity to serve healthcare professionals globally is massive, and no one is better positioned than FIGS to capitalize on it.”
Full Year 2025 Financial Highlights
•Net revenues were $631.1 million, an increase of 13.6% year over year, primarily driven by an increase in orders from new and existing customers and higher AOV.(3)
•Scrubwear net revenues were $508.9 million, an increase of 14.3% year over year.
•Non-scrubwear net revenues were $122.2 million, an increase of 10.6% year over year.
•U.S. net revenues were $527.5 million, an increase of 11.2% year over year.
•International net revenues were $103.6 million, an increase of 27.5% year over year.
•Gross margin was 66.5%, a decrease of 110 basis points year over year, primarily due to higher tariffs and the inventory write-off recorded in Q4 2025, partially offset by a lower discount rate.
•Operating expenses were $381.7 million, an increase of 2.2% year over year. As a percentage of net revenues, operating expenses decreased to 60.5% from 67.2% in the same period last year, primarily due to lower stock-based compensation expense, lower fulfillment expenses and higher brand marketing expenses in the prior year related to our 2024 Olympics campaign.
•Net income was $34.3 million, or $0.19 in diluted earnings per share, compared to net income of $2.7 million, or $0.02 in diluted earnings per share, in the same period last year.
•Net income margin(2) was 5.4%, as compared to 0.5% in the same period last year.
•Adjusted EBITDA(3) was $74.5 million, an increase of $22.7 million year over year.
•Adjusted EBITDA margin(2)(3) was 11.8%, as compared to 9.3% in the same period last year.
•Free Cash Flow(3) was $53.0 million.
Full Year 2025 Key Operating Metrics
•Active customers(1) as of December 31, 2025 increased 9.4% year over year to 2.9 million.
•Net revenues per active customer(1) was $216, an increase of 3.8% year over year.
•AOV(1) was $120, an increase of 6.2% year over year, primarily driven by higher average unit retail due to product mix, higher units per transaction, and favorable discount and return rates.
Full Year 2026 Financial Outlook
Net Revenues growth vs. 2025 | up 10% to 12% | ||||
Adjusted EBITDA Margin(2)(4) | 12.7% to 12.9% | ||||
Sarah Oughtred, Chief Financial Officer, commented, “We exited 2025 with tremendous demand momentum, improving profitability and record cash on the balance sheet—each measure well ahead of expectations and a testament to the strength of our strategy and execution of our team. Our success positions us for a great 2026 with continuing growth from the core foundational elements of our business as well as from International, TEAMS and Community Hubs. Given our momentum and while still adopting a prudent mindset, we expect top line growth in 2026 of 10-12%, including growth in the low-20% range for Q1. At the same time, we expect increased profitability, even with the latest announcement calling for 15% global tariffs. Finally, our balance sheet remains a source of strength and financial flexibility, and we expect that to improve even further with strong cash flow driving expanded shareholder value.”
(1) “Active customers,” “net revenues per active customer” and “average order value” are key operational and business metrics that are important to understanding the Company’s performance. Please see the sections titled “Non-GAAP Financial Measures and Key Operating Metrics” and “Key Operating Metrics” below for information regarding how the Company calculates its key operational and business metrics and for comparisons of active customers, net revenues per active customer and average order value to the prior year period.
(2) “Net income margin” and “adjusted EBITDA margin” are calculated by dividing net income and adjusted EBITDA by net revenues, respectively.
(3) “Adjusted EBITDA,” “adjusted EBITDA margin” and “free cash flow” are non-GAAP financial measures. Please see the sections titled “Non-GAAP Financial Measures and Key Operating Metrics” and “Reconciliations of GAAP to Non-GAAP Measures” below for more information regarding the Company’s use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.
(4) The Company has not provided a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income outlook because it is unable, without making unreasonable efforts, to project certain reconciling items. These items include, but are not limited to,
future stock-based compensation expense, income taxes, expenses related to non-ordinary course disputes, and transaction costs. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company’s control or ability to predict. For more information regarding the Company’s use of non-GAAP financial measures, please see the section titled “Non-GAAP Financial Measures and Key Operating Metrics.”
Conference Call Details
FIGS management will host a conference call and webcast today at 2:00 p.m. PT / 5:00 p.m. ET to discuss the Company’s financial and business results and outlook. To participate, please dial 1-646-844-6383 (US) or 1-833-470-1428 (International) and the conference ID 223631. The call is also accessible via webcast at ir.wearfigs.com. A recording will be available shortly after the conclusion of the call until 11:59 p.m. ET on March 5, 2026. To access the replay, please dial 1-929-458-6194 (US) or 1-866-813-9403 (International) and the conference ID 957212. An archive of the webcast will be available on FIGS’ investor relations website at ir.wearfigs.com.
Non-GAAP Financial Measures and Key Operating Metrics
In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. The Company uses “adjusted EBITDA” and “adjusted EBITDA margin” to provide useful supplemental measures that assist in evaluating its ability to generate earnings, provide consistency and comparability with its past financial performance and facilitate period-to-period comparisons of its core operating results as well as the results of its peer companies. The Company uses “free cash flow” as a useful supplemental measure of liquidity and as an additional basis for assessing its ability to generate cash. The Company calculates “adjusted EBITDA” as net income adjusted to exclude: other income (loss), net; gain/loss on disposal of assets; provision for income taxes; depreciation and amortization expense; stock-based compensation and related expense; transaction costs; and expenses related to non-ordinary course disputes. The Company calculates “adjusted EBITDA margin” by dividing adjusted EBITDA by net revenues. The Company calculates “free cash flow” as net cash (used in) provided by operating activities reduced by capital expenditures, including purchases of property and equipment and capitalized software development costs.
Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included below under the heading “Reconciliations of GAAP to Non-GAAP Measures.”
The Company has also included herein “active customers,” “net revenues per active customer” and “average order value,” which are key operational and business metrics that are important to understanding Company performance. The Company believes the number of active customers is an important indicator of growth as it reflects the reach of the Company’s digital platform, brand awareness and overall value proposition. The Company defines an active customer as a unique customer account that has made at least one purchase in the preceding 12-month period. In any particular period, the Company determines the number of active customers by counting the total number of customers who have made at least one purchase in the preceding 12-month period, measured from the last date of such period. The Company believes measuring net revenues per active customer is important to understanding engagement and retention of customers, and as such, the value proposition for its customer base. The Company defines net revenues per active customer as the sum of total net revenues in the preceding 12-month period divided by the current period active customers. The Company defines average order value as the sum of the total net revenues in a given period divided by the total orders placed in that period. Total orders are the summation of all completed individual purchase transactions in a given period. The Company believes its relatively high average order value demonstrates the premium nature of its products. As the Company expands into and increases its presence in additional product categories, price points and international markets, average order value may fluctuate.
Active customers as of December 31, 2025 and 2024, respectively, net revenues per active customer as of December 31, 2025 and 2024, respectively, and average order value for the years ended December 31, 2025 and 2024, respectively, are presented below under the heading “Key Operating Metrics.”
About FIGS
FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower, and serve current and future generations of healthcare professionals. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function, and style. We share stories about healthcare professionals’ experiences in ways that inspire them. We build meaningful connections within the healthcare community that we created. Above all, we seek to make an impact for our community, including by advocating for them and always having their backs.
We serve healthcare professionals both in the U.S. and internationally. We also serve healthcare institutions through our TEAMS platform.
Forward Looking Statements
This press release contains various forward-looking statements about the Company within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are based on current management expectations, and which involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, such forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words “anticipate”, “believe”, “contemplate”, “continue”, “could”, “estimate”, “expect”, “forecast”, “future”, “intend”, “may”, “might”, “opportunity”, “outlook”, “plan”, “possible”, “potential”, “predict”, “project,” “should”, “strategy”, “strive”, “target”, “will” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including the Company’s tailwinds, the Company’s opportunity and positioning to serve healthcare professionals globally; the Company’s expectations for 2026 with continuing growth from the core foundational elements of its business and from International, TEAMS and Community Hubs; the Company’s expectation of topline growth in 2026 of 10-12%, including its growth expectations in the low-20% range for Q1; the Company’s expectation of increased profitability; the Company’s tariff expectations; the Company’s expectations regarding its balance sheet; the Company’s expectation that strong cash flow will drive expanded shareholder value; and the information under the section titled “Full Year 2026 Financial Outlook,” such as the Company’s outlook as to net revenues growth and adjusted EBITDA margin for the full year ending December 31, 2026; all of which reflect the Company’s expectations based upon currently available information and data. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, the Company’s actual results, performance or achievements may differ materially from those expressed or implied by the forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements. The following important factors and uncertainties, among others, could cause actual results, performance or achievements to differ materially from those described in these forward-looking statements: the Company’s ability to maintain its historical growth; the Company’s ability to maintain profitability; the Company’s ability to maintain the value and reputation of its brand; the Company’s ability to attract new customers, retain existing customers, and to maintain or increase sales to those customers; the success of the Company’s marketing efforts; the Company’s ability to maintain a strong community of engaged customers and Ambassadors; negative publicity related to the Company’s marketing efforts or use of social media; the Company’s ability to successfully develop and introduce new, innovative and updated products; the competitiveness of the market for healthcare apparel; the Company’s ability to maintain its key employees; the Company’s ability to attract and retain highly skilled team members; risks associated with expansion into, and conducting business in, international markets; changes in, or disruptions to, the Company’s shipping arrangements; the successful operation of the Company’s fulfillment operations; the Company’s ability to accurately forecast customer demand, manage its inventory, and plan for future expenses; the impact of changes in consumer confidence, shopping behavior and consumer spending on demand for the Company’s products; the impact of macroeconomic trends on the Company’s operations; the Company’s reliance on a limited number of third-party suppliers; the impact of global trade policy on the Company’s ability to source and distribute its products; the fluctuating costs of raw materials; the Company’s ability to executed on its B2B growth strategy; the Company’s ability to execute on its retail growth strategy; the Company’s failure to protect proprietary, confidential or sensitive information or personal customer data or risks of cyberattacks; the Company’s failure to protect its intellectual property rights; the fact that the operations of many of the Company’s suppliers and
vendors are subject to additional risks that are beyond its control; and other risks, uncertainties and factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 to be filed with the Securities and Exchange Commission (“SEC”), and the Company’s other periodic filings with the SEC. The forward-looking statements in this press release speak only as of the time made and the Company does not undertake to update or revise them to reflect future events or circumstances.
FIGS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
| As of | |||||||||||
| December 31, 2025 | December 31, 2024 | ||||||||||
| Assets | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | $ | 81,985 | $ | 85,645 | |||||||
| Short-term investments | 218,863 | 159,469 | |||||||||
| Accounts receivable | 6,271 | 8,625 | |||||||||
| Inventory, net | 127,966 | 115,759 | |||||||||
| Prepaid expenses and other current assets | 12,200 | 13,268 | |||||||||
| Total current assets | 447,285 | 382,766 | |||||||||
| Non-current assets | |||||||||||
| Property and equipment, net | 33,938 | 35,274 | |||||||||
| Operating lease right-of-use assets | 57,134 | 50,497 | |||||||||
| Deferred tax assets | 12,187 | 11,643 | |||||||||
| Investment in equity securities | 27,735 | 27,534 | |||||||||
| Other assets | 1,717 | 2,073 | |||||||||
| Total non-current assets | 132,711 | 127,021 | |||||||||
| Total assets | $ | 579,996 | $ | 509,787 | |||||||
| Liabilities and stockholders’ equity | |||||||||||
| Current liabilities | |||||||||||
| Accounts payable | $ | 18,187 | $ | 9,401 | |||||||
| Operating lease liabilities | 8,175 | 10,596 | |||||||||
| Accrued expenses | 20,529 | 42,316 | |||||||||
| Accrued compensation and benefits | 17,194 | 5,689 | |||||||||
| Sales tax payable | 4,266 | 3,705 | |||||||||
| Gift card liability | 12,117 | 9,604 | |||||||||
| Deferred revenue | 3,990 | 4,612 | |||||||||
| Returns reserve | 4,171 | 3,873 | |||||||||
| Income tax payable | 1,894 | 346 | |||||||||
| Total current liabilities | 90,523 | 90,142 | |||||||||
| Non-current liabilities | |||||||||||
| Operating lease liabilities, non-current | 51,829 | 42,430 | |||||||||
| Other non-current liabilities | 182 | 83 | |||||||||
| Total liabilities | 142,534 | 132,655 | |||||||||
| Commitments and contingencies | |||||||||||
| Stockholders’ equity | |||||||||||
Class A common stock — par value $0.0001 per share, 1,000,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 157,559,556 and 154,003,352 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 16 | 15 | |||||||||
Class B common stock — par value $0.0001 per share, 150,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 8,283,641 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | — | — | |||||||||
Preferred stock — par value $0.0001 per share, 100,000,000 shares authorized as of December 31, 2025 and December 31, 2024; zero shares issued and outstanding as of December 31, 2025 and December 31, 2024 | — | — | |||||||||
| Additional paid-in capital | 338,526 | 312,622 | |||||||||
| Accumulated other comprehensive income | 196 | 21 | |||||||||
| Retained earnings | 98,724 | 64,474 | |||||||||
| Total stockholders’ equity | 437,462 | 377,132 | |||||||||
| Total liabilities and stockholders’ equity | $ | 579,996 | $ | 509,787 | |||||||
FIGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
| Three months ended December 31, | Year ended December 31, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (unaudited) | |||||||||||||||||||||||
| Net revenues | $ | 201,896 | $ | 151,832 | $ | 631,098 | $ | 555,558 | |||||||||||||||
| Cost of goods sold | 74,830 | 49,636 | 211,259 | 179,935 | |||||||||||||||||||
| Gross profit | 127,066 | 102,196 | 419,839 | 375,623 | |||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
| Selling | 42,899 | 37,917 | 145,851 | 141,909 | |||||||||||||||||||
| Marketing | 28,326 | 19,788 | 93,105 | 88,566 | |||||||||||||||||||
| General and administrative | 37,033 | 35,591 | 142,736 | 142,883 | |||||||||||||||||||
| Total operating expenses | 108,258 | 93,296 | 381,692 | 373,358 | |||||||||||||||||||
| Net income from operations | 18,808 | 8,900 | 38,147 | 2,265 | |||||||||||||||||||
| Other income, net | |||||||||||||||||||||||
| Interest income | 2,238 | 2,639 | 8,748 | 11,242 | |||||||||||||||||||
Other income | 307 | 841 | 312 | 833 | |||||||||||||||||||
| Total other income, net | 2,545 | 3,480 | 9,060 | 12,075 | |||||||||||||||||||
| Net income before provision for income taxes | 21,353 | 12,380 | 47,207 | 14,340 | |||||||||||||||||||
| Provision for income taxes | 2,846 | 10,495 | 12,957 | 11,620 | |||||||||||||||||||
| Net income | $ | 18,507 | $ | 1,885 | $ | 34,250 | $ | 2,720 | |||||||||||||||
| Earnings attributable to Class A and Class B common stockholders | |||||||||||||||||||||||
| Basic earnings per share | $ | 0.11 | $ | 0.01 | $ | 0.21 | $ | 0.02 | |||||||||||||||
| Diluted earnings per share | $ | 0.10 | $ | 0.01 | $ | 0.19 | $ | 0.02 | |||||||||||||||
| Weighted-average shares outstanding—basic | 165,003,284 | 166,343,035 | 163,462,072 | 169,201,983 | |||||||||||||||||||
| Weighted-average shares outstanding—diluted | 190,008,150 | 178,588,552 | 179,486,886 | 180,102,840 | |||||||||||||||||||
FIGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| Year ended December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ | 34,250 | $ | 2,720 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization expense | 9,035 | 6,694 | |||||||||
| Deferred income taxes | (544) | 6,648 | |||||||||
| Non-cash operating lease cost | 9,996 | 8,483 | |||||||||
| Stock-based compensation | 26,874 | 42,673 | |||||||||
| Accretion of discount and accrued interest on available-for-sale securities | (3,727) | (6,499) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable | 2,354 | (1,219) | |||||||||
| Inventory | (12,207) | 3,281 | |||||||||
| Prepaid expenses and other current assets | 1,068 | (2,544) | |||||||||
| Other assets | 356 | (737) | |||||||||
| Accounts payable | 8,757 | (5,332) | |||||||||
| Accrued expenses | (21,289) | 33,950 | |||||||||
| Accrued compensation and benefits | 11,505 | (1,623) | |||||||||
| Sales tax payable | 561 | 556 | |||||||||
| Gift card liability | 2,513 | 1,364 | |||||||||
| Deferred revenue | (622) | 2,452 | |||||||||
| Returns reserve | 298 | 884 | |||||||||
| Income tax payable | 1,548 | (2,211) | |||||||||
| Operating lease liabilities | (9,655) | (8,278) | |||||||||
| Other non-current liabilities | 99 | (100) | |||||||||
Net cash provided by operating activities | 61,170 | 81,162 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Purchases of property and equipment | (8,168) | (17,021) | |||||||||
| Purchases of available-for-sale securities | (256,992) | (246,949) | |||||||||
| Maturities of available-for-sale securities | 201,400 | 196,580 | |||||||||
| Purchase of investment in equity securities | (201) | (27,534) | |||||||||
| Net cash used in investing activities | (63,961) | (94,924) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Repurchases of Class A Common Stock | (2,688) | (45,454) | |||||||||
| Proceeds from stock option exercises and employee stock purchases | 1,718 | 438 | |||||||||
Issuance of Class A Common Stock upon vesting of restricted stock | 1 | — | |||||||||
| Issuance of Class A Common Stock in exchange for services | — | 250 | |||||||||
Net cash used in financing activities | (969) | (44,766) | |||||||||
Effect of foreign currency exchange rate changes on cash and cash equivalents | 100 | — | |||||||||
Net decrease in cash and cash equivalents | (3,660) | (58,528) | |||||||||
Cash and cash equivalents, beginning of period | $ | 85,645 | $ | 144,173 | |||||||
| Cash and cash equivalents end of period | $ | 81,985 | $ | 85,645 | |||||||
FIGS, INC.
RECONCILIATIONS OF GAAP TO NON-GAAP MEASURES
(Unaudited)
The following table presents a reconciliation of adjusted EBITDA to net income, which is the most directly comparable financial measure calculated in accordance with GAAP, and presents adjusted EBITDA margin with net income margin, which is the most directly comparable financial measure calculated in accordance with GAAP:
| Three Months Ended December 31, | Year Ended December 31, | |||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (in thousands, except margin) | ||||||||||||||||||||||||||
| Net income | $ | 18,507 | $ | 1,885 | $ | 34,250 | $ | 2,720 | ||||||||||||||||||
| Add (deduct): | ||||||||||||||||||||||||||
| Other income, net | (2,545) | (3,481) | (9,060) | (12,075) | ||||||||||||||||||||||
| Provision for income taxes | 2,846 | 10,494 | 12,957 | 11,620 | ||||||||||||||||||||||
Depreciation and amortization expense(1) | 2,557 | 1,847 | 9,035 | 6,694 | ||||||||||||||||||||||
Stock-based compensation and related expense(2) | 5,369 | 10,331 | 27,304 | 42,837 | ||||||||||||||||||||||
Adjusted EBITDA(3) | $ | 26,734 | $ | 21,076 | $ | 74,486 | $ | 51,796 | ||||||||||||||||||
| Net Revenues | $ | 201,896 | $ | 151,832 | $ | 631,098 | $ | 555,558 | ||||||||||||||||||
Net income margin(4) | 9.2 | % | 1.2 | % | 5.4 | % | 0.5 | % | ||||||||||||||||||
| Adjusted EBITDA Margin | 13.2 | % | 13.9 | % | 11.8 | % | 9.3 | % | ||||||||||||||||||
(1) Excludes amortization of debt issuance costs included in “Other income, net.”
(2) Includes stock-based compensation expense, payroll taxes, and costs related to equity award activity.
(3) For the year ended December 31, 2025, reflects $171,000 of stock-based compensation expense and payroll taxes inadvertently not reflected in our previously disclosed Adjusted EBITDA results for the three months ended March 31, 2025.
(4) Net income margin represents net income as a percentage of net revenues.
The following table presents a reconciliation of free cash flow to net cash provided by operating activities, which is the most directly comparable financial measure calculated in accordance with GAAP:
| Year ended December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| (in thousands) | |||||||||||
| Net cash provided by operating activities | $ | 61,170 | $ | 81,162 | |||||||
| Less: capital expenditures | (8,168) | (17,021) | |||||||||
| Free cash flow | $ | 53,002 | $ | 64,141 | |||||||
FIGS, INC.
KEY OPERATING METRICS
(Unaudited)
Active customers as of December 31, 2025 and 2024, respectively, net revenues per active customer as of December 31, 2025 and 2024, respectively, and average order value for the years ended December 31, 2025 and 2024, respectively, are presented in the following tables:
| As of December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| (in thousands) | |||||||||||
| Active customers | 2,921 | 2,670 | |||||||||
| As of December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Net revenues per active customer | $ | 216 | $ | 208 | |||||||
| Year ended December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Average order value | $ | 120 | $ | 113 | |||||||
FIGS, INC.
DISAGGREGATED NET REVENUES
(In thousands, except percentages)
The following table presents the disaggregation of the Company’s net revenues for the years and three months ended December 31, 2025 and December 31, 2024:
| Year ended December 31, | Change | ||||||||||||||||
| 2025 | 2024 | % | |||||||||||||||
| By geography: | |||||||||||||||||
| United States | $ | 527,466 | $ | 474,305 | 11.2 | % | |||||||||||
| Rest of the world | 103,632 | 81,253 | 27.5 | % | |||||||||||||
| $ | 631,098 | $ | 555,558 | 13.6 | % | ||||||||||||
| By product: | |||||||||||||||||
| Scrubwear | $ | 508,902 | $ | 445,112 | 14.3 | % | |||||||||||
| Non-Scrubwear | 122,196 | 110,446 | 10.6 | % | |||||||||||||
| $ | 631,098 | $ | 555,558 | 13.6 | % | ||||||||||||
| Three months ended December 31, | Change | ||||||||||||||||
| 2025 | 2024 | % | |||||||||||||||
(Unaudited) | |||||||||||||||||
| By geography: | |||||||||||||||||
| United States | $ | 164,156 | $ | 127,504 | 28.7 | % | |||||||||||
| Rest of the world | 37,740 | 24,328 | 55.1 | % | |||||||||||||
| $ | 201,896 | $ | 151,832 | 33.0 | % | ||||||||||||
| By product: | |||||||||||||||||
| Scrubwear | $ | 154,903 | $ | 114,653 | 35.1 | % | |||||||||||
| Non-Scrubwear | 46,993 | 37,179 | 26.4 | % | |||||||||||||
| $ | 201,896 | $ | 151,832 | 33.0 | % | ||||||||||||
Contacts
Investors:
Tom Shaw
IR@wearfigs.com
Media:
Todd Maron
press@wearfigs.com
Filing Exhibits & Attachments
4 documents
Figs Inc
NYSE:FIGS
FIGS Rankings
FIGS Latest News
Feb 25, 2026
FIGS Announces Participation in the Raymond James 47th Annual Institutional Investors Conference
Feb 5, 2026
FIGS Announces Date of Fourth Quarter and Full Year 2025 Earnings Release, Conference Call and Webcast
FIGS Latest SEC Filings
Feb 26, 2026
[10-K] FIGS, Inc. Files Annual Report
Feb 9, 2026
[Form 4] FIGS, Inc. Insider Trading Activity
Feb 9, 2026
[Form 4] FIGS, Inc. Insider Trading Activity
FIGS Stock Data
1.80B
148.47M
Apparel Manufacturing
Apparel & Other Finishd Prods of Fabrics & Similar Matl
United States
SANTA MONICA